去纤苷全网公布的2024年的最新价格

Introduction: Defibrotide is used to treat adults and children with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), and renal or pulmonary dysfunction after hematopoietic stem cell transplantation (HSCT). Defibrinoside increases the activity of plasmin, an enzyme that breaks down many proteins in the blood, including fibrin, which forms blood clots.

The latest price of defibrotide in 2024 announced on the entire website

The latest price in 2024 is approximately between 38,500$-38,900$, and the specification of one box is 200mg/2.5mL/bottle. It may vary due to changes in exchange rates, market demand, purchasing channels and other factors. The actual transaction price must prevail when purchasing. Drug prices may be affected by multiple factors such as production costs, market demand, supply chain stability, policies and regulations, and therefore may change. If you need to obtain the latest price or have other inquiries about defibrotide, it is recommended to contact a professional medical consultation service for assistance.

The reason why defibrotide is expensive

1. High research and development costs: Defibrotide is a drug used to treat a specific rare disease, hepatic veno-occlusive disease (VOD). Its research and development process requires a lot of time and capital investment, thus increasing production costs.

2. Complex production process: The production of defibrotide may involve complex biotechnological processes, including extraction from pig intestinal mucosa and subsequent purification steps, which may increase production costs.

3. Limited market demand: Since defibrotide is used to treat rare diseases, its target patient group is relatively small and the market demand is limited, which may lead to higher unit costs.

4. Limited supply: The supply of defibrotide may be limited by production capacity and raw material sources, and limited supply may also lead to price increases.

5. Patent protection: As a patented drug, defibrotide is not allowed to be produced by other companies during the patent protection period, which may also lead to higher prices.

6. Medical insurance coverage: Medical insurance policies in different regions may affect the final selling price of drugs. If medical insurance does not cover it or the coverage is limited, patients may need to pay for it out of pocket, which will be reflected in the price of the drug.